2022
DOI: 10.1016/j.brachy.2021.12.004
|View full text |Cite
|
Sign up to set email alerts
|

Permanent interstitial brachytherapy for prostate cancer implementing neoadjuvant prostatic artery embolization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 47 publications
0
1
0
Order By: Relevance
“…PAE could then be associated with other therapies without interfering on their mechanisms of action. For example, PAE has been described before permanent interstitial brachytherapy for patients with a large prostate, reporting the same oncological efficacy and fewer side effects (17).…”
mentioning
confidence: 99%
“…PAE could then be associated with other therapies without interfering on their mechanisms of action. For example, PAE has been described before permanent interstitial brachytherapy for patients with a large prostate, reporting the same oncological efficacy and fewer side effects (17).…”
mentioning
confidence: 99%